KRT9 anticorps (AA 429-456)
Aperçu rapide pour KRT9 anticorps (AA 429-456) (ABIN5533217)
Antigène
Voir toutes KRT9 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- AA 429-456
-
Purification
- This antibody is prepared by Saturated Ammonium Sulfate (SAS) precipitation followed by dialysis
-
Immunogène
- This KRT9 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 429-456 amino acids from the Central region of human KRT9.
-
Isotype
- Ig Fraction
-
-
-
-
Indications d'application
- For WB starting dilution is: 1:1000
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 2 mg/mL
-
Buffer
- Supplied in PBS with 0.09 % (W/V) sodium azide.
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- 4 °C,-20 °C
-
Stockage commentaire
- Store at 4°C for three months and -20°C, stable for up to one year. As with all antibodies care should be taken to avoid repeated freeze thaw cycles. Antibodies should not be exposed to prolonged high temperatures.
-
-
- KRT9 (Keratin 9 (KRT9))
-
Autre désignation
- KRT9
-
Sujet
- KRT9 is the type I keratin 9, an intermediate filament chain expressed only in the terminally differentiated epidermis of palms and soles. Mutations in this protein cause epidermolytic palmoplantar keratoderma.
-
Poids moléculaire
- 62 kDa
-
ID gène
- 3857
-
UniProt
- P35527
Antigène
-